Show Stocks and Investing Publications • Thu, August 1, 2024
Greg Harrison Maintained (UTHR) at Sell with Decreased Target to $280 on, Aug 1st, 2024
on-maintained-uthr-at-sell-with-decreased-target-to-280-on-aug-1st-2024.html
Stocks and Investing on Mon, Oct 28th, 2024Greg Harrison of B of A Securities, Maintained "United Therapeutics Corporation" (UTHR) at Sell with Decreased Target from $303 to $280 on, Aug 1st, 2024.
Greg has made no other calls on UTHR in the last 4 months.
There are 7 other peers that have a rating on UTHR. Out of the 7 peers that are also analyzing UTHR, 2 agree with Greg's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Terence Flynn of "Morgan Stanley" Downgraded from Buy to Hold and Increased Target to $321 on, Thursday, July 11th, 2024
- Chris Shibutani of "Goldman Sachs" Maintained at Hold with Increased Target to $240 on, Friday, May 3rd, 2024
These are the ratings of the 5 analyists that currently disagree with Greg
- Joseph Thome of "TD Cowen" Maintained at Strong Buy with Increased Target to $350 on, Thursday, July 11th, 2024
- Ashwani Verma of "UBS" Maintained at Strong Buy with Increased Target to $370 on, Monday, July 8th, 2024
- Tiago Fauth of "Wells Fargo" Maintained at Buy with Increased Target to $350 on, Wednesday, June 12th, 2024
- Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $300 on, Tuesday, May 21st, 2024
- Hartaj Singh of "Oppenheimer" Maintained at Buy with Increased Target to $400 on, Thursday, May 2nd, 2024